Is It Safe to Stop Anti-PD-1 Immunotherapy in Patients With Metastatic Melanoma Who Achieve a Complete Response?

J Clin Oncol. 2020 May 20;38(15):1645-1647. doi: 10.1200/JCO.20.00136. Epub 2020 Feb 25.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Humans
  • Immunotherapy / adverse effects
  • Melanoma* / drug therapy